This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Makita, N. Articles by Kitabatake, A. Search for Related Content PubMed PubMed Citation Articles by Makita, N. Articles by Kitabatake, A. Pubmed/NCBI databases Gene GEO Profiles HomoloGene OMIM Protein UniGene Related Collections Clinical genetics Arrythmias-basic studies Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2000;101:54.)
© 2000 American Heart Association, Inc.

Clinical Investigation and Reports

Cardiac Na⁺ Channel Dysfunction in Brugada Syndrome Is Aggravated by ß₁-Subunit

Naomasa Makita, MD, PhD; Nobumasa Shirai, MD; Dao W. Wang, MD; Koji Sasaki, MD; Alfred L. George, Jr, MD; Morio Kanno, MD, PhD; Akira Kitabatake, MD, PhD

From the Department of Cardiovascular Medicine (N.M., N.S., K.S., A.K.) and Department of Pharmacology (M.K.), Hokkaido University School of Medicine, Sapporo, Japan, and the Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine (D.W.W., A.L.G.), Nashville, Tenn.

Correspondence to Naomasa Makita, MD, PhD, Department of Cardiovascular Medicine, Hokkaido University School of Medicine, Kita-15, Nishi-7, Kita-Ku, Sapporo 060-8638, Japan. E-mail makitan{at}med.hokudai.ac.jp

Background—Mutations in the gene encoding the human cardiac Na⁺ channel -subunit (hH1) are responsible for chromosome 3–linked congenital long-QT syndrome (LQT3) and idiopathic ventricular fibrillation (IVF). An auxiliary ß₁-subunit, widely expressed in excitable tissues, shifts the voltage dependence of steady-state inactivation toward more negative potentials and restores normal gating kinetics of brain and skeletal muscle Na⁺ channels expressed in Xenopus oocytes but has little if any functional effect on the cardiac isoform. Here, we characterize the altered effects of a human ß₁-subunit (hß₁) on the heterologously expressed hH1 mutation (T1620M) previously associated with IVF.

Methods and Results—When expressed alone in Xenopus oocytes, T1620M exhibited no persistent currents, in contrast to the LQT3 mutant channels, but the midpoint of steady-state inactivation (V_1/2) was significantly shifted toward more positive potentials than for wild-type hH1. Coexpression of hß₁ did not significantly alter current decay or recovery from inactivation of wild-type hH1; however, it further shifted the V_1/2 and accelerated the recovery from inactivation of T1620M. Oocyte macropatch analysis revealed that the activation kinetics of T1620M were normal.

Conclusions—It is suggested that coexpression of hß₁ exposes a more severe functional defect that results in a greater overlap in the relationship between channel inactivation and activation (window current) in T1620M, which is proposed to be a potential pathophysiological mechanism of IVF in vivo. One possible explanation for our finding is an altered -/ß₁-subunit association in the mutant.

Key Words: action potentials • arrhythmia • death, sudden • electrophysiology • fibrillation

This article has been cited by other articles:

				J. M. Cordeiro, H. Barajas-Martinez, K. Hong, E. Burashnikov, R. Pfeiffer, A.-M. Orsino, Y. S. Wu, D. Hu, J. Brugada, P. Brugada, et al. Compound Heterozygous Mutations P336L and I1660V in the Human Cardiac Sodium Channel Associated With the Brugada Syndrome Circulation, November 7, 2006; 114(19): 2026 - 2033. [Abstract] [Full Text] [PDF]

				K. M. Kahlig, S. N. Misra, and A. L. George Jr Impaired Inactivation Gate Stabilization Predicts Increased Persistent Current for an Epilepsy-Associated SCN1A Mutation J. Neurosci., October 25, 2006; 26(43): 10958 - 10966. [Abstract] [Full Text] [PDF]

				P. J. Stocker and E. S. Bennett Differential Sialylation Modulates Voltage-gated Na+ Channel Gating throughout the Developing Myocardium J. Gen. Physiol., February 27, 2006; 127(3): 253 - 265. [Abstract] [Full Text] [PDF]

				K. H. W. J. ten Tusscher, D. Noble, P. J. Noble, and A. V. Panfilov A model for human ventricular tissue Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1573 - H1589. [Abstract] [Full Text] [PDF]

				H. L Tan, C. R Bezzina, J. P.P Smits, A. O Verkerk, and A. A.M Wilde Genetic control of sodium channel function Cardiovasc Res, March 15, 2003; 57(4): 961 - 973. [Abstract] [Full Text] [PDF]

				M Takagi, N Aihara, S Kuribayashi, A Taguchi, T Kurita, K Suyama, S Kamakura, and M Takamiya Abnormal response to sodium channel blockers in patients with Brugada syndrome: augmented localised wall motion abnormalities in the right ventricular outflow tract region detected by electron beam computed tomography Heart, February 1, 2003; 89(2): 169 - 174. [Abstract] [Full Text] [PDF]

				T. Bohle, M. C. Brandt, M. Lindner, and D. J. Beuckelmann Identification of Gating Modes in Single Native Na+ Channels From Human Atrium and Ventricle Circ. Res., September 6, 2002; 91(5): 421 - 426. [Abstract] [Full Text] [PDF]

				N. Makita, M. Horie, T. Nakamura, T. Ai, K. Sasaki, H. Yokoi, M. Sakurai, I. Sakuma, H. Otani, H. Sawa, et al. Drug-Induced Long-QT Syndrome Associated With a Subclinical SCN5A Mutation Circulation, September 3, 2002; 106(10): 1269 - 1274. [Abstract] [Full Text] [PDF]

				M. Vatta, R. Dumaine, G. Varghese, T. A. Richard, W. Shimizu, N. Aihara, K. Nademanee, R. Brugada, J. Brugada, G. Veerakul, et al. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome Hum. Mol. Genet., February 1, 2002; 11(3): 337 - 345. [Abstract] [Full Text] [PDF]

				N. Shirai, N. Makita, K. Sasaki, H. Yokoi, I. Sakuma, H. Sakurada, J. Akai, A. Kimura, M. Hiraoka, and A. Kitabatake A mutant cardiac sodium channel with multiple biophysical defects associated with overlapping clinical features of Brugada syndrome and cardiac conduction disease Cardiovasc Res, February 1, 2002; 53(2): 348 - 354. [Abstract] [Full Text] [PDF]

				I. Cavero and W. Crumb Native and cloned ion channels from human heart: laboratory models for evaluating the cardiac safety of new drugs Eur. Heart J. Suppl., September 1, 2001; 3(suppl_K): K53 - K63. [Abstract] [PDF]

				C. R Bezzina, M. B Rook, and A. A.M Wilde Cardiac sodium channel and inherited arrhythmia syndromes Cardiovasc Res, February 1, 2001; 49(2): 257 - 271. [Full Text] [PDF]

				X. Wan, S. Chen, A. Sadeghpour, Q. Wang, and G. E. Kirsch Accelerated inactivation in a mutant Na+ channel associated with idiopathic ventricular fibrillation Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H354 - H360. [Abstract] [Full Text] [PDF]

				D. W. Wang, N. Makita, A. Kitabatake, J. R. Balser, and A. L. George Jr Enhanced Na+ Channel Intermediate Inactivation in Brugada Syndrome Circ. Res., October 13, 2000; 87 (8): e37 - e43. [Abstract] [Full Text] [PDF]

				G. Baroudi, S. Acharfi, C. Larouche, and M. Chahine Expression and Intracellular Localization of an SCN5A Double Mutant R1232W/T1620M Implicated in Brugada Syndrome Circ. Res., January 11, 2002; 90 (1): e11 - e16. [Abstract] [Full Text] [PDF]